Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01383837 · ClinicalTrials.gov registry record · Phase 1
HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment
A Phase 1 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 86
- Enrollment target
NCT01383837 is a Phase 1 study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 86 participants.
The verdict
NCT01383837, a Phase 1 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 86 participants
- Enrollment target
Study Summary
Adolescents with substance use disorders (SUD) are at substantial risk for contracting HIV/STIs compared to their counterparts without SUD, yet few HIV/STI sexual risk reduction interventions have been developed to meet their unique needs, and none use a family-based intervention approach, which the literature recommends as the focus for intervention for youth. Current state policies neither require providers in clinics delivering substance use treatment to offer HIV/STI sexual risk reduction nor offer providers tools or training for HIV/STI prevention. There is clear public health need to develop innovative methods of service delivery and effective strategies of HIV/STI sexual risk reduction that address multiple contexts of risk (i.e. family) for this high risk population. The current proposal addresses this need by developing a provider-delivered HIV sexual risk reduction intervention to be implemented in outpatient SUD treatment that: 1) builds the clinics' capacity to help families under their care to more comfortably address the adolescent's sexuality; 2) promotes youth's safer sex practices; and 3) reduces HIV/STI sexual risk behaviors among adolescents with SUD in care.
Interventions
- BEHAVIORAL Health Promotion
- BEHAVIORAL STYLEnS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2010-08 |
| Est. Completion | 2015-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01383837
The ClinicalTrials.gov registry entry for NCT01383837 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Health Promotion is the first listed.
NCT01383837 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01383837 about?
NCT01383837 is a clinical study titled "HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment". Adolescents with substance use disorders (SUD) are at substantial risk for contracting HIV/STIs compared to their counterparts without SUD, yet few HIV/STI sexual risk reduction interventions have been developed to meet their unique needs, and none use a family-based intervention approach, which the...
What is the current status of trial NCT01383837?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 86 participants. The study started on 2010-08. Estimated completion is 2015-08.
What interventions are being tested in trial NCT01383837?
The interventions under investigation include: Health Promotion (BEHAVIORAL), STYLEnS (BEHAVIORAL).
Who is sponsoring clinical trial NCT01383837?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.